Form 8-K - Current report:
SEC Accession No. 0001437749-23-024856
Filing Date
2023-08-30
Accepted
2023-08-30 07:00:31
Documents
14
Period of Report
2023-08-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K amtx20230828_8k.htm   iXBRL 8-K 27761
2 EXHIBIT 3.1 AMENDMENT TO BY-LAWS ex_565813.htm EX-3.1 161870
  Complete submission text file 0001437749-23-024856.txt   360720

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amtx-20230824.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amtx-20230824_def.xml EX-101.DEF 12187
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amtx-20230824_lab.xml EX-101.LAB 16396
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amtx-20230824_pre.xml EX-101.PRE 12457
8 EXTRACTED XBRL INSTANCE DOCUMENT amtx20230828_8k_htm.xml XML 2739
Mailing Address 20400 STEVENS CREEK BLVD SUITE 700 CUPERTINO CA 95014
Business Address 20400 STEVENS CREEK BLVD SUITE 700 CUPERTINO CA 95014 408-517-3304
AEMETIS, INC (Filer) CIK: 0000738214 (see all company filings)

EIN.: 261407544 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36475 | Film No.: 231223678
SIC: 2860 Industrial Organic Chemicals